Cardiovascular Diseases (CVDs), including coronary artery disease, heart failure, and stroke, remain the leading cause of death worldwide, underscoring the critical need for early diagnosis and targeted treatments. Traditional risk factors such as hypertension, hyperlipidemia, diabetes, and smoking have long been used to assess the likelihood of cardiovascular events. However, these factors often fail to predict disease onset in individuals who appear to be at low risk. As a result, there is growing interest in identifying novel biomarkers that can provide more precise and early detection of cardiovascular diseases.
Received: 01 October, 2024, Manuscript No. jmbd-25-157283; Editor Assigned: 03 October, 2024, PreQC No. P-157283; Reviewed: 14 October, 2024, QC No. Q-157283; Revised: 21 October, 2024, Manuscript No. R-157283; Published: 28 October, 2024, DOI: 10.37421/2155-9929.2024.15. 662.
HTML PDFShare this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
